Mid-infrared spectroscopy of 1-cyanonaphthalene cation for astrochemical consideration.

We present the low temperature gas-phase vibrational spectrum of ionised 1-cyanonaphthalene (1-CNN+) in the mid-infrared region. Experimentally, 1-CNN+ ions are cooled below 10 K in a cryogenic ion trapping apparatus, tagged with He atoms and probed with tuneable radiation. Quantum-chemical calculations are carried out at a density functional theory level. The spectrum is dominated by the CN-stretch at 4.516 µm, with weaker CH modes near 3.2 µm.

Electronic Spectroscopy of Monocyclic Carbon Ring Cations for Astrochemical Consideration.

Gas phase electronic spectra of pure carbon cations generated by laser vaporization of graphite in a supersonic jet and cooled to below 10 K and tagged with helium atoms in a cryogenic trap are presented. The measured C2n+-He with n from 6 to 14, are believed to be monocyclic ring structures and possess an origin band wavelength that shifts linearly with the number of carbon atoms, as recently demonstrated through N2 tagging by Buntine et al. ( J. Chem. Phys. 2021, 155, 214302). The set of data presented here further constrains the spectral characteristics inferred for the bare C2n+ ions to facilitate astronomical searches for them in diffuse clouds by absorption spectroscopy.

Fullerenes in Space.

In 1985 the football structure of C60 , buckminsterfullerene was proposed and subsequently confirmed following its macroscopic synthesis in 1990. From the very beginning the role of C60 and C60+ in space was considered, particularly in the context of the enigmatic diffuse interstellar bands. These are absorption features found in the spectra of reddened star light. The first astronomical observations were made around one hundred years ago and despite significant efforts none of the interstellar molecules responsible have been identified. The absorption spectrum of C60+ was measured in a 5 K neon matrix in 1993 and two prominent bands near 9583 Šand 9645 Šwere observed. On the basis of this data the likely wavelength range in which the gas phase C60+ absorptions should lie was predicted. In 1994 two diffuse interstellar bands were found in this spectral region and proposed to be due to C60+ . It took over 20 years to measure the absorption spectrum of C60+ under conditions similar to those prevailing in diffuse clouds. In 2015, sophisticated laboratory experiments led to the confirmation that these two interstellar bands are indeed caused by C60+ , providing the first answer to this century old puzzle. Here, we describe the experiments, concepts and astronomical observations that led to the detection of C60+ in interstellar space.

Pathway to the identification of C60+ in diffuse interstellar clouds.

The origin of the attenuation of starlight in diffuse clouds in interstellar space at specific wavelengths ranging from the visible to the near-infrared has been unknown since the first astronomical observations around a century ago. The absorption features, termed the diffuse interstellar bands, have subsequently been the subject of much research. Earlier this year four of these interstellar bands were shown to be due to the absorption by cold, gas phase [Formula: see text] molecules. This discovery provides the first answer to the problem of the diffuse interstellar bands and leads naturally to fascinating questions regarding the role of fullerenes and derivatives in interstellar chemistry. Here, we review the identification process placing special emphasis on the laboratory studies which have enabled spectroscopic measurement of large cations cooled to temperatures prevailing in the interstellar medium.This article is part of the themed issue 'Fullerenes: past, present and future, celebrating the 30th anniversary of Buckminster Fullerene'.

Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis.

Regulation of spermatogonial maintenance in the human testis is currently not well understood. One pathway suggested to be involved is activated by fibroblast growth factor receptor 3 (FGFR3), which is expressed in a subset of spermatogonia. FGFR3-activating mutations have been identified in spermatocytic seminoma, thought to originate from clonal expansion of spermatogonia. In this study we aimed to characterize potential binding partners of FGFR3, and specifically its mesenchymal "c" splice isoform, in human spermatogonia. Based on expression patterns and homology to the binding site, we identified FGF1, FGF2, and FGF9 as the best candidates for natural ligands of FGFR3c in the testis. In addition, we screened non-FGF proteins and found that a proteoglycan biglycan (BGN) contains a sequence homologous to the FGFR3c binding site on FGF1, and is expressed in peritubular cells adjacent to FGFR3-expressing spermatogonia. Experiments in a cell-free system confirmed that BGN binds to FGFR3c and FGF1. In conclusion, our findings further clarify the complex regulation of FGFR3c in the human testis. We postulate that BGN is a factor secreted by peritubular cells to modulate FGFR3c signaling and thus contributes to the regulation of spermatogonial maintenance.

Comparison of image quality using a X-ray stereotactical whole-body system and a direct flat-panel X-ray device in examinations of the pelvis and knee.

PURPOSE: The novel biplanar X-ray unit "EOS", EOS Imaging, allows to acquire simultaneously 2 perpendicular planes of full-length spine and limbs and to measure spatially correct angles based on the acquired image data sets. This is to be seen alongside with a low spatial resolution, high investment costs and high operating expenses. The use of the biplanar X-ray unit in morphology based scelettal radiography might improve the cost-benefit-relation. Thus, the purpose of this study was to compare image quality of the EOS-unit and the flat panel (FP)-technology as reference in a clinical setting. MATERIALS AND METHODS: All 114 patients of the Orthopedic Hospital Dept., who had a biplanar full-length lower limb radiograph and a FP-examination of the pelvis and/or the knee with maximum time interval of 3 months without changes in the clinical and radiological findings were included in the study. All X-ray examinations had been carried out due to clinical indications. Secondary captures comparable to the FP-images were extracted from the electronic EOS-image data sets. 4 radiologists independently from each other compared the visualization of normal anatomical structures of the pseudonymous EOS- and FP-images in a randomized order. RESULTS: In the overwiew of all readers and all sceletal regions image quality of the FP-images was considered being superior in a mean of 83 ±â€Š13 % standard deviation of the pair comparisons (minimum 48 %, maximum 100 %). Image quality of the EOS-images was assessed as being superior in 2 ±â€Š3 % of the cases (0 %, 10 %). Image quality of 0.8 ±â€Š3 % of the FP-images (0 %, 17 %) and 30 ±â€Š34 % (0 %, 100 %) of the EOS-images was estimated as diagnostically inadequate. 30 ±â€Š33 % of the pair comparisons (0 %, 100 %) showed a diagnostically inadequate image quality of the EOS-images and a diagnostically good image quality of the FP-images. CONCLUSION: Image quality of biplanar full-length lower limb X-ray examinations is not suitable to be used for the diagnostic assessment of the morphological bone structure using the currently available technological setting. KEY POINTS: ▶ biplanar full-length lower limb X-ray examinations ▶ plat-panel radiography ▶ image quality.

[Reducing radiation exposure for patient and staff during interventional radiology demonstrated for coil embolisation]. / Reduzierung der Strahlenexposition für Patienten und Personal bei radiologischen Interventionen am Beispiel der Coilembolisation.

PURPOSE: Coil embolization of intracranial aneurysms is a radiographic interventional procedure associated with relatively high radiation exposure for the patient and staff. Modern angiographic fluoroscopy systems have a high potential for reducing radiation exposure of a wide bandwidth (e. g. automatic beam filtering, pulsed fluoroscopy, characteristic curve selection). The purpose of this study was to determine how those features could be implemented in the daily routine. MATERIAL AND METHODS: The radiation exposure for the patient and staff was measured during 60 coiling procedures and compared to the mean values before changing the parameters. RESULTS: Implementation of those dose-reducing features during complex radiographic procedures is limited for various reasons. A 35 % dose reduction during coil embolization was able to be achieved in our trial. CONCLUSIONS: From an economic point of view, some resources implemented by the manufacturer and included in the prime cost of the system are not being fully utilized. With some effort, instruction and further education of the staff could lead to a further reduction in radiation exposure without losing too much image quality.

[Which points deserve special attention in the new guidelines on X-ray use (testing guidelines for experts and quality assurance guidelines)?]. / Was muss bei den neuen Richtlinien zur Röntgenverordnung (Sachverständigenprüfrichtlinie und Qualitätssicherungsrichtlinie) besonders beachtet werden?

Two important guidelines for the application of X-rays in medicine became effective on 1 October 2003 and 1 December 2003. These are testing guidelines for experts and quality assurance guidelines. Both guidelines are very extensive and not always easy to interpret. In the present paper the authors try to explain in detail some chapters important for radiology and to make the necessary technical background transparent. Both authors took an essential part in forming the guidelines.

[5 years of "concerted action dose reduction in CT" -- what has been achieved and what remains to be done?]. / 5 Jahre Konzertierte Aktion Dosisreduktion CT--was wurde erreicht, was ist noch zu tun?

In May 1998, the German "Concerted Action Dose Reduction in CT" was founded by all parties involved in CT. Its intention was to achieve a significant reduction of the radiation exposure caused by CT, a matter that has increasingly been considered a major challenge since the early nineties. As a result of a number of joint efforts, the essential preconditions have been established by now. The fifth anniversary of the Concerted Action gave rise for both retrospection and outlook on the tasks that have already been accomplished and those that still need to be done. For this purpose, a one-day symposium took place in Berlin on November 4, 2003. The contents of a total of 18 contributions will be outlined here in brief.

Dose reduction in multi-slice CT of the heart by use of ECG-controlled tube current modulation ("ECG pulsing"): phantom measurements.

PURPOSE: To evaluate the effect of ECG-controlled tube current modulation on radiation exposure in retrospectively-ECG-gated multislice CT (MSCT) of the heart. MATERIAL AND METHODS: Three different cardiac MSCT protocols with different slice collimation (4 x 1, and 4 x 2.5mm), and a pitch-factor of 1.5 and 1.8 were investigated at a multi-slice CT scanner Somatom Volume Zoom, Siemens. An anthropomorphic Alderson-Rando phantom was equipped with LiF-thermoluminescence dosimeters at several organ sites, and effective doses were calculated using ICRP-weighting factors. Scan protocols were performed with ECG-controlled tube current modulation ("ECG pulsing") at two different heart rates (60 and 80 bpm). These data were compared to previous data from MSCT of the heart without use of "ECG pulsing". RESULTS: Radiation exposure with (60 bpm) and without tube current modulation using a 2.5 mm collimation was 1.8 mSv and 2.9 mSv for females, and 1.5 mSv and 2.4 mSv for males, respectively. For protocols using a 1 mm collimation with a pitch-factor of 1.5 (1.8), radiation exposure with and without tube current modulation was 5.6 (6.3) mSv and 9.5 (11.2) mSv for females, and 4.6 (5.2) mSv and 7.7 (9.2) mSv for males, respectively. At higher heart rates (80 bpm) radiation exposure is increased from 1.5 - 1.8 mSv to 1.8 - 2.1 mSv, using the 2.5 mm collimation, and from 4.6 - 5.6 mSv to 5.9 - 7.2 mSv, for protocols using 1 mm collimation. CONCLUSIONS: The ECG-controlled tube current modulation allows a dose reduction of 37 % to 44 % when retrospectively ECG-gated MSCT of the heart is performed. The tube current - as a function over time - and therefore the radiation exposure is dependent on the heart rate.

A genome screen of a large bipolar affective disorder pedigree supports evidence for a susceptibility locus on chromosome 13q.

Bipolar affective disorder is a severe mood disorder that afflicts approximately 1% of the population worldwide. Twin and adoption studies have indicated that genetic factors contribute to the disorder and while many chromosomal regions have been implicated, no susceptibility genes have been identified. In this present study, we undertook a 10 cM genome screen using 400 microsatellite markers in a large multigenerational bipolar pedigree consisting of 40 individuals, including six affecteds. We found strongest evidence for linkage to chromosome 13q14. A maximum NPL score of 4.09 (P = 0.008) was obtained between markers D13S1272 and D13S153 using GENEHUNTER. A maximum two-point LOD score of 2.91 (theta = 0.0) was found for marker D13S153 and a maximum three-point LOD score of 3.0 was obtained between markers D13S291 and D13S153 under a recessive model with 90% maximum age-specific penetrance and including bipolar I and unipolar individuals as affected. Several other markers in the region, D13S175, D13S218, D13S263, and D13S156 had two-point LOD scores greater than 1.5. These results meet the criteria for evidence of suggestive linkage. Haplotype analysis enabled us to narrow the likely disease region to a 6 cM region between markers D13S1272 and D13S1319, which contains the serotonin 2A receptor candidate gene. Two single nucleotide polymorphisms were identified in this gene but we did not detect any significant differences in allele frequency in a case-control sample. The region on chromosome 13q14-32 has previously been implicated in other bipolar and schizophrenia cohorts. Our results provide further support for the existence of a susceptibility locus on chromosome 13q14.

Radiation exposure in multi-slice CT of the heart.

PURPOSE: To assess radiation exposure of patients undergoing Multi-Row Detector CT (Multi-Slice CT, MSCT) of the heart. MATERIAL AND METHODS: Four different cardiac MSCT protocols with changing slice collimation (4 x 1, and 4 x 2.5 mm), and pitch-factor (1.5, 1.8, and 4) were examined. An anthropomorphic Alderson-Rando phantom was equipped with LiF-thermoluminescent dosimeters at several organ sites, and effective doses were calculated using ICRP-weighting factors. These data were compared to data from standard MSCT of chest and abdomen. RESULTS: Effective dose in different protocols for cardiac MSCT varies from 2.8 to 10.3 mSv (male), and from 3.6 to 12.7 mSv (female). In protocols with thin collimation and low pitch or a combination of several heart examinations, radiation exposure may be comparable to the effective dose of standard MSCT of the chest (male: 11.9 mSv, female: 12.9 mSv) or the abdomen (male: 16.1 mSv, female: 15.7 mSv). Highest organ doses were found for the female breast (up to 46.6 mGy), and the lungs (up to 36.4 mGy) with surface doses as high as 54.3 mGy. CONCLUSIONS: Cardiac MSCT adds significantly to the radiation exposure of patients and can reach the effective dose applied by standard MSCT of chest or abdomen.

Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample.

In a previous genome scan of 43 schizophrenia pedigrees, nonparametric linkage (NPL) scores with empirically derived pointwise P-values less than 0.01 were observed in two regions (chromosomes 2q12-13 and 10q23) and less than 0.05 in three regions (4q22-23, 9q22, and 11q21). Markers with a mean spacing of about 5 cM were typed in these regions in an expanded sample of 71 pedigrees, and NPL analyses carried out. No region produced significant genomewide evidence for linkage. On chromosome 10q, the empirical P-value remained at less than 0.01 for the entire sample (D10S168), evidence in the original 43 pedigrees was slightly increased, and a broad peak of positive results was observed. P-values less than 0.05 were observed on chromosomes 2q (D2S436) and 4q (D4S2623), but not on chromosomes 9q or 11q. It is concluded that this sample is most supportive of linkage on chromosome 10q, with less consistent support on chromosomes 2q and 4q. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:864-869, 2000.

Identification and analysis of error types in high-throughput genotyping.

Although it is clear that errors in genotyping data can lead to severe errors in linkage analysis, there is as yet no consensus strategy for identification of genotyping errors. Strategies include comparison of duplicate samples, independent calling of alleles, and Mendelian-inheritance-error checking. This study aimed to develop a better understanding of error types associated with microsatellite genotyping, as a first step toward development of a rational error-detection strategy. Two microsatellite marker sets (a commercial genomewide set and a custom-designed fine-resolution mapping set) were used to generate 118,420 and 22,500 initial genotypes and 10,088 and 8,328 duplicates, respectively. Mendelian-inheritance errors were identified by PedManager software, and concordance was determined for the duplicate samples. Concordance checking identifies only human errors, whereas Mendelian-inheritance-error checking is capable of detection of additional errors, such as mutations and null alleles. Neither strategy is able to detect all errors. Inheritance checking of the commercial marker data identified that the results contained 0.13% human errors and 0.12% other errors (0.25% total error), whereas concordance checking found 0.16% human errors. Similarly, Mendelian-inheritance-error checking of the custom-set data identified 1.37% errors, compared with 2.38% human errors identified by concordance checking. A greater variety of error types were detected by Mendelian-inheritance-error checking than by duplication of samples or by independent reanalysis of gels. These data suggest that Mendelian-inheritance-error checking is a worthwhile strategy for both types of genotyping data, whereas fine-mapping studies benefit more from concordance checking than do studies using commercial marker data. Maximization of error identification increases the likelihood of linkage when complex diseases are analyzed.

Maternal uniparental isodisomy for chromosome 14 detected prenatally.

Maternal uniparental disomy (UPD) for chromosome 14 (upd(14)mat) has been associated with a distinct phenotype. We describe the first case of maternal uniparental isodisomy for chromosome 14 detected prenatally, in a pregnancy with mosaicism for trisomy 14 observed in both a chorionic villus sample (CVS) and in amniocytes. Detailed analysis of polymorphic microsatellites showed that the fetus was essentially isodisomic for one of the mother's chromosomes 14 and that recombination had introduced a mid-long arm region of heterodisomy. The fetus, which died in utero at 18 weeks, showed no apparent pathological features. The case demonstrates for the first time a maternal meiosis II non-disjunction of chromosome 14 leading to a trisomic conception which has been incompletely corrected by 'rescue' in the early embryo.

[Aspects of radiation protection in cardiovascular brachytherapy]. / Strahlenschutzaspekte in der kardiovaskulären Brachytherapie.

In the scope of cardiovascular brachytherapy beta- as well as gamma-ray emitting radionuclides are used. The handling of radioactive sources is within the range of the radiation protection regulations (Strahlenschutzverordnung [StrlSch V]). According to EU guidelines an amendment of the StrlSch V is required by May 2000. The connected reduction of dose limits now should already be taken into consideration when planning irradiation facilities, likewise in cardiovascular brachytherapy. Temporary regulations for equipment that was already in operation before May 2000 are not planned in the new StrlSch V.